aap: Preliminary Sales Figures for Fiscal 2006 (+40%)


aap Implantate AG, a medical technology company listed in the Prime Standard Segment on the Frankfurt Stock Exchange and specialized in biomaterials and implants for trauma and joint reconstruction, boosted sales by 40% in fiscal 2006 to EUR 18.6 million from the previous year’s EUR 13.3 million.

Sales growth was achieved mainly in Biomaterials (orthopedic and dental bone replacement materials, bone cements and infection care), with sales up by more than 70% on the year (EUR 12,7 million versus EUR 7,4 million in 2005).

aap anticipates a further significant increase in sales this year.  2007 sales, including those of the Dutch Fame Medical Group, are expected to amount to around EUR 30 million.

The full aap Implantate AG annual financial statements for 2006 will be published on March 30, 2007.